Published in Managed Care Business Week, November 22nd, 2005
The beneficial effect was retained for over 3 months. Worldwide rights to the development and commercialization of the new technology are exclusively licensed to BrainStorm.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Business Week